Dividend Informer Q3 2024 Update: Abbott Laboratories

Shares remain priced at a premium after a quarter meeting analysts' expectations.

Here is the Dividend Informer team’s update on a covered stock. See below for updated buy/sell prices, a report on recent conditions and expectations for the future, and current analysis metrics.

Medical Devices are a large market for our focus stock.